You are not alone. Here is where to start: learn the basics, find a specialist or center that sees ALG2-congenital disorder of glycosylation, look for clinical trials, and connect with others living with it — all in one place.
Open the full ALG2-congenital disorder of glycosylation hub →ALG2-congenital disorder of glycosylation is a rare condition. Also known as CDG syndrome type Ii, CDG-Ii, CDG1I, Carbohydrate deficient glycoprotein syndrome type Ii, Congenital disorder of glycosylation type 1i, Congenital disorder of glycosylation type Ii, Mannosyltransferase 2 deficiency. Tomeko brings together the specialists, research, clinical trials, treatments and community for ALG2-congenital disorder of glycosylation so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.
Identifiers: ORPHA:79326 · OMIM 607906 · ICD-10 E77.8 · GARD 0009836
Start by learning the basics from an authoritative source, find a specialist or center that sees ALG2-congenital disorder of glycosylation, and connect with a patient organization. Tomeko brings these together on one hub.
Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat ALG2-congenital disorder of glycosylation, filtered to your area.
Tomeko shows live, recruiting studies for ALG2-congenital disorder of glycosylation from ClinicalTrials.gov on the hub.